Apolipoprotein A1 in Cerebrospinal Fluid Is Insufficient to Distinguish Alzheimer's Disease from Other Dementias in a Naturalistic, Clinical Setting.
Journal of Alzheimer's disease reports 2020 Feb 4 (1): 15-19.
Stoye Nicolai Maximilian, Jung Patrick, Guilherme Malena Dos Santos, Lotz Johannes, Fellgiebel Andreas, Endres Kristi
An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009 Feb 15 (2): 174-9.
Koutsis G, Panas M, Giogkaraki E, Karadima G, Sfagos C, Vassilopoulos